Nilotinib treatment-associated peripheral artery disease and sudden death: yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia. (Q54586024)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nilotinib treatment-associated peripheral artery disease and sudden death: yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia. |
scientific article |
Statements
Nilotinib treatment-associated peripheral artery disease and sudden death: yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia. (English)
1 reference
Ayalew Tefferi
1 reference
Louis Letendre
1 reference
31 May 2011
1 reference
86
1 reference
7
1 reference
610-611
1 reference
Identifiers
1 reference